
NEW YORK, Sept. 16, 2022 /PRNewswire/ -- The Vaginal Ring Market report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.
The potential growth difference for the vaginal ring market between 2021 and 2026 is USD 519.39 million. The report extensively covers vaginal ring market segmentation by distribution channel (pharmacies and clinics and online retail) and geography (North America, Europe, Asia, and the Rest of World (ROW)). To get the exact yearly growth variance and the Y-O-Y growth rate, Buy Sample Report.
- Market Driver
- Market Challenges
One of the key drivers supporting the growth of the vaginal ring market is consumers' progressive attitude toward contraception. An increasingly progressive attitude toward premarital sex encourages the use of female contraceptives such as vaginal rings, increasing their popularity and social acceptance. Because of increased awareness and availability, acceptance of these products is expected to grow across all age groups.
The current generation of 18-25-year-olds are looking for ways to improve their sexual experience, and vaginal rings are a low-cost alternative to contraception. However, factors such as the availability of alternative methods of contraception will challenge market growth. Request Free Sample Report.
North America will account for 53% of market growth. The United States and Canada are the two most important markets in North America for vaginal rings. The market in this region will grow at a slower rate than the market in other regions. High contraceptive awareness and rising acceptance of new products will help the vaginal ring market grow in North America over the forecast period.
The pharmacies and clinics segment will gain a significant share of the vaginal ring market. Online retail is another area where vendors can see significant growth. When compared to buying and selling products and services in brick-and-mortar stores, the internet has reduced the time required to buy and sell products and services.
The availability of a wide range of products, quick delivery services, and competitive prices are all factors that contribute to online retail's success.
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
- AbbVie Inc.
- Bayer AG
- Johnson and Johnson
- Merck and Co. Inc.
- Novo Nordisk AS
- Pfizer Inc.
- Prasco Laboratories
- QPharma Inc.
- SMB Corp. of India
- TherapeuticsMD Inc.
To gain access to more vendor profiles with their key offerings available with Technavio, Download Free Sample Here.
Age-Related Macular Degeneration (AMD) Therapeutics Market by Type and Geography - Forecast and Analysis 2022-2026: The age-related macular degeneration market share is expected to increase by USD 9.37 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.6%.
PCR System for Food Diagnostics Market by Product and Geography - Forecast and Analysis 2022-2026: The PCR system for food diagnostics market share is expected to increase by USD 977.11 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.31%.
Vaginal Ring Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.44% |
Market growth 2022-2026 |
$ 519.39 million |
Market structure |
Concentrated |
YoY growth (%) |
3.76 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 53% |
Key consumer countries |
US, Canada, Germany, UK, and France |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
AbbVie Inc., Bayer AG, Johnson and Johnson, Merck and Co. Inc., Novo Nordisk AS, Pfizer Inc., Prasco Laboratories, QPharma Inc., SMB Corp. of India, and TherapeuticsMD Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio "Health Care" Research Reports
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Distribution Channel
- 5.1 Market segments
- Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
- 5.2 Comparison by Distribution Channel
- Exhibit 26: Chart on Comparison by Distribution Channel
- Exhibit 27: Data Table on Comparison by Distribution Channel
- 5.3 Pharmacies and clinics - Market size and forecast 2021-2026
- Exhibit 28: Chart on Pharmacies and clinics - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Pharmacies and clinics - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Pharmacies and clinics - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Pharmacies and clinics - Year-over-year growth 2021-2026 (%)
- 5.4 Online retail - Market size and forecast 2021-2026
- Exhibit 32: Chart on Online retail - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Online retail - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Online retail - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Online retail - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Distribution Channel
- Exhibit 36: Market opportunity by Distribution Channel ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Canada - Market size and forecast 2021-2026
- Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.9 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.11 France - Market size and forecast 2021-2026
- Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 AbbVie Inc.
- Exhibit 85: AbbVie Inc. - Overview
- Exhibit 86: AbbVie Inc. - Product / Service
- Exhibit 87: AbbVie Inc. - Key offerings
- 10.4 Bayer AG
- Exhibit 88: Bayer AG - Overview
- Exhibit 89: Bayer AG - Business segments
- Exhibit 90: Bayer AG - Key offerings
- Exhibit 91: Bayer AG - Segment focus
- 10.5 Johnson and Johnson
- Exhibit 92: Johnson and Johnson - Overview
- Exhibit 93: Johnson and Johnson - Business segments
- Exhibit 94: Johnson and Johnson - Key news
- Exhibit 95: Johnson and Johnson - Key offerings
- Exhibit 96: Johnson and Johnson - Segment focus
- 10.6 Merck and Co. Inc.
- Exhibit 97: Merck and Co. Inc. - Overview
- Exhibit 98: Merck and Co. Inc. - Business segments
- Exhibit 99: Merck and Co. Inc. - Key news
- Exhibit 100: Merck and Co. Inc. - Key offerings
- Exhibit 101: Merck and Co. Inc. - Segment focus
- 10.7 Novo Nordisk AS
- Exhibit 102: Novo Nordisk AS - Overview
- Exhibit 103: Novo Nordisk AS - Business segments
- Exhibit 104: Novo Nordisk AS - Key offerings
- Exhibit 105: Novo Nordisk AS - Segment focus
- 10.8 Pfizer Inc.
- Exhibit 106: Pfizer Inc. - Overview
- Exhibit 107: Pfizer Inc. - Product / Service
- Exhibit 108: Pfizer Inc. - Key news
- Exhibit 109: Pfizer Inc. - Key offerings
- 10.9 Prasco Laboratories
- Exhibit 110: Prasco Laboratories - Overview
- Exhibit 111: Prasco Laboratories - Product / Service
- Exhibit 112: Prasco Laboratories - Key offerings
- 10.10 QPharma Inc.
- Exhibit 113: QPharma Inc. - Overview
- Exhibit 114: QPharma Inc. - Product / Service
- Exhibit 115: QPharma Inc. - Key offerings
- 10.11 SMB Corp. of India
- Exhibit 116: SMB Corp. of India - Overview
- Exhibit 117: SMB Corp. of India - Product / Service
- Exhibit 118: SMB Corp. of India - Key offerings
- 10.12 TherapeuticsMD Inc.
- Exhibit 119: TherapeuticsMD Inc. - Overview
- Exhibit 120: TherapeuticsMD Inc. - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 121: Inclusions checklist
- Exhibit 122: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 123: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 124: Research methodology
- Exhibit 125: Validation techniques employed for market sizing
- Exhibit 126: Information sources
- 11.5 List of abbreviations
- Exhibit 127: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article